nodes	percent_of_prediction	percent_of_DWPC	metapath
Cinoxacin—SLC22A6—Captopril—systemic scleroderma	0.545	0.76	CbGbCtD
Cinoxacin—SLC22A6—Methotrexate—systemic scleroderma	0.172	0.24	CbGbCtD
Cinoxacin—Tingling sensation—Mometasone—systemic scleroderma	0.00738	0.026	CcSEcCtD
Cinoxacin—Tingling sensation—Leflunomide—systemic scleroderma	0.00534	0.0188	CcSEcCtD
Cinoxacin—Drowsiness—Pentoxifylline—systemic scleroderma	0.00384	0.0136	CcSEcCtD
Cinoxacin—Photophobia—Lisinopril—systemic scleroderma	0.00346	0.0122	CcSEcCtD
Cinoxacin—Eosinophilia—Captopril—systemic scleroderma	0.00324	0.0114	CcSEcCtD
Cinoxacin—Photophobia—Mycophenolate mofetil—systemic scleroderma	0.00303	0.0107	CcSEcCtD
Cinoxacin—Toxic epidermal necrolysis—Azathioprine—systemic scleroderma	0.00297	0.0105	CcSEcCtD
Cinoxacin—Stevens-Johnson syndrome—Captopril—systemic scleroderma	0.00289	0.0102	CcSEcCtD
Cinoxacin—Toxic epidermal necrolysis—Leflunomide—systemic scleroderma	0.00281	0.0099	CcSEcCtD
Cinoxacin—Angioedema—Pentoxifylline—systemic scleroderma	0.00275	0.00968	CcSEcCtD
Cinoxacin—Eosinophilia—Leflunomide—systemic scleroderma	0.00267	0.00941	CcSEcCtD
Cinoxacin—Stevens-Johnson syndrome—Azathioprine—systemic scleroderma	0.00252	0.00889	CcSEcCtD
Cinoxacin—Erythema multiforme—Captopril—systemic scleroderma	0.00247	0.00872	CcSEcCtD
Cinoxacin—Anaphylactic shock—Pentoxifylline—systemic scleroderma	0.00245	0.00865	CcSEcCtD
Cinoxacin—Oedema—Pentoxifylline—systemic scleroderma	0.00245	0.00865	CcSEcCtD
Cinoxacin—Toxic epidermal necrolysis—Lisinopril—systemic scleroderma	0.00241	0.00851	CcSEcCtD
Cinoxacin—Thrombocytopenia—Pentoxifylline—systemic scleroderma	0.0024	0.00847	CcSEcCtD
Cinoxacin—Stevens-Johnson syndrome—Leflunomide—systemic scleroderma	0.00238	0.0084	CcSEcCtD
Cinoxacin—Angioedema—Mometasone—systemic scleroderma	0.00237	0.00836	CcSEcCtD
Cinoxacin—Anorexia—Pentoxifylline—systemic scleroderma	0.00234	0.00825	CcSEcCtD
Cinoxacin—Eosinophilia—Lisinopril—systemic scleroderma	0.00229	0.00808	CcSEcCtD
Cinoxacin—Insomnia—Pentoxifylline—systemic scleroderma	0.00222	0.00782	CcSEcCtD
Cinoxacin—Somnolence—Pentoxifylline—systemic scleroderma	0.00218	0.00769	CcSEcCtD
Cinoxacin—Erythema multiforme—Azathioprine—systemic scleroderma	0.00216	0.00761	CcSEcCtD
Cinoxacin—Decreased appetite—Pentoxifylline—systemic scleroderma	0.00213	0.00752	CcSEcCtD
Cinoxacin—Anaphylactic shock—Mometasone—systemic scleroderma	0.00212	0.00746	CcSEcCtD
Cinoxacin—Angioedema—Captopril—systemic scleroderma	0.00208	0.00734	CcSEcCtD
Cinoxacin—Stevens-Johnson syndrome—Lisinopril—systemic scleroderma	0.00205	0.00722	CcSEcCtD
Cinoxacin—Erythema multiforme—Leflunomide—systemic scleroderma	0.00204	0.00719	CcSEcCtD
Cinoxacin—Anorexia—Mometasone—systemic scleroderma	0.00202	0.00711	CcSEcCtD
Cinoxacin—Gastrointestinal pain—Pentoxifylline—systemic scleroderma	0.002	0.00707	CcSEcCtD
Cinoxacin—Urticaria—Pentoxifylline—systemic scleroderma	0.00195	0.00687	CcSEcCtD
Cinoxacin—Abdominal pain—Pentoxifylline—systemic scleroderma	0.00194	0.00684	CcSEcCtD
Cinoxacin—Tinnitus—Mycophenolic acid—systemic scleroderma	0.00192	0.00676	CcSEcCtD
Cinoxacin—Paraesthesia—Mometasone—systemic scleroderma	0.0019	0.0067	CcSEcCtD
Cinoxacin—Anaphylactic shock—Captopril—systemic scleroderma	0.00186	0.00656	CcSEcCtD
Cinoxacin—Decreased appetite—Mometasone—systemic scleroderma	0.00184	0.00649	CcSEcCtD
Cinoxacin—Thrombocytopenia—Captopril—systemic scleroderma	0.00182	0.00642	CcSEcCtD
Cinoxacin—Pain—Mometasone—systemic scleroderma	0.00181	0.00638	CcSEcCtD
Cinoxacin—Hypersensitivity—Pentoxifylline—systemic scleroderma	0.00181	0.00637	CcSEcCtD
Cinoxacin—Anorexia—Captopril—systemic scleroderma	0.00177	0.00625	CcSEcCtD
Cinoxacin—Erythema multiforme—Lisinopril—systemic scleroderma	0.00175	0.00618	CcSEcCtD
Cinoxacin—Pruritus—Pentoxifylline—systemic scleroderma	0.00173	0.00612	CcSEcCtD
Cinoxacin—Gastrointestinal pain—Mometasone—systemic scleroderma	0.00173	0.0061	CcSEcCtD
Cinoxacin—Tinnitus—Lisinopril—systemic scleroderma	0.00173	0.00609	CcSEcCtD
Cinoxacin—Angioedema—Leflunomide—systemic scleroderma	0.00171	0.00605	CcSEcCtD
Cinoxacin—Insomnia—Captopril—systemic scleroderma	0.00168	0.00593	CcSEcCtD
Cinoxacin—Diarrhoea—Pentoxifylline—systemic scleroderma	0.00168	0.00592	CcSEcCtD
Cinoxacin—Abdominal pain—Mometasone—systemic scleroderma	0.00167	0.0059	CcSEcCtD
Cinoxacin—Paraesthesia—Captopril—systemic scleroderma	0.00167	0.00589	CcSEcCtD
Cinoxacin—Somnolence—Captopril—systemic scleroderma	0.00165	0.00583	CcSEcCtD
Cinoxacin—Dizziness—Pentoxifylline—systemic scleroderma	0.00162	0.00572	CcSEcCtD
Cinoxacin—Decreased appetite—Captopril—systemic scleroderma	0.00162	0.0057	CcSEcCtD
Cinoxacin—Thrombocytopenia—Azathioprine—systemic scleroderma	0.00159	0.0056	CcSEcCtD
Cinoxacin—Vomiting—Pentoxifylline—systemic scleroderma	0.00156	0.0055	CcSEcCtD
Cinoxacin—Rash—Pentoxifylline—systemic scleroderma	0.00155	0.00545	CcSEcCtD
Cinoxacin—Dermatitis—Pentoxifylline—systemic scleroderma	0.00154	0.00545	CcSEcCtD
Cinoxacin—Headache—Pentoxifylline—systemic scleroderma	0.00154	0.00542	CcSEcCtD
Cinoxacin—Anaphylactic shock—Leflunomide—systemic scleroderma	0.00153	0.0054	CcSEcCtD
Cinoxacin—Gastrointestinal pain—Captopril—systemic scleroderma	0.00152	0.00536	CcSEcCtD
Cinoxacin—Tinnitus—Mycophenolate mofetil—systemic scleroderma	0.00151	0.00534	CcSEcCtD
Cinoxacin—Thrombocytopenia—Leflunomide—systemic scleroderma	0.0015	0.00529	CcSEcCtD
Cinoxacin—Pruritus—Mometasone—systemic scleroderma	0.0015	0.00528	CcSEcCtD
Cinoxacin—Angioedema—Lisinopril—systemic scleroderma	0.00147	0.0052	CcSEcCtD
Cinoxacin—Abdominal pain—Captopril—systemic scleroderma	0.00147	0.00518	CcSEcCtD
Cinoxacin—Oedema—Mycophenolic acid—systemic scleroderma	0.00146	0.00515	CcSEcCtD
Cinoxacin—Anorexia—Leflunomide—systemic scleroderma	0.00146	0.00515	CcSEcCtD
Cinoxacin—Nausea—Pentoxifylline—systemic scleroderma	0.00146	0.00514	CcSEcCtD
Cinoxacin—Diarrhoea—Mometasone—systemic scleroderma	0.00145	0.00511	CcSEcCtD
Cinoxacin—Thrombocytopenia—Mycophenolic acid—systemic scleroderma	0.00143	0.00505	CcSEcCtD
Cinoxacin—Anorexia—Mycophenolic acid—systemic scleroderma	0.00139	0.00491	CcSEcCtD
Cinoxacin—Insomnia—Leflunomide—systemic scleroderma	0.00139	0.00489	CcSEcCtD
Cinoxacin—Paraesthesia—Leflunomide—systemic scleroderma	0.00138	0.00485	CcSEcCtD
Cinoxacin—Vomiting—Mometasone—systemic scleroderma	0.00135	0.00475	CcSEcCtD
Cinoxacin—Rash—Mometasone—systemic scleroderma	0.00133	0.00471	CcSEcCtD
Cinoxacin—Dermatitis—Mometasone—systemic scleroderma	0.00133	0.0047	CcSEcCtD
Cinoxacin—Decreased appetite—Leflunomide—systemic scleroderma	0.00133	0.0047	CcSEcCtD
Cinoxacin—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.00133	0.00468	CcSEcCtD
Cinoxacin—Headache—Mometasone—systemic scleroderma	0.00133	0.00468	CcSEcCtD
Cinoxacin—Insomnia—Mycophenolic acid—systemic scleroderma	0.00132	0.00466	CcSEcCtD
Cinoxacin—Oedema—Lisinopril—systemic scleroderma	0.00132	0.00464	CcSEcCtD
Cinoxacin—Anaphylactic shock—Lisinopril—systemic scleroderma	0.00132	0.00464	CcSEcCtD
Cinoxacin—Pruritus—Captopril—systemic scleroderma	0.00131	0.00464	CcSEcCtD
Cinoxacin—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.00131	0.00463	CcSEcCtD
Cinoxacin—Pain—Leflunomide—systemic scleroderma	0.00131	0.00462	CcSEcCtD
Cinoxacin—Somnolence—Mycophenolic acid—systemic scleroderma	0.0013	0.00458	CcSEcCtD
Cinoxacin—Angioedema—Mycophenolate mofetil—systemic scleroderma	0.00129	0.00455	CcSEcCtD
Cinoxacin—Thrombocytopenia—Lisinopril—systemic scleroderma	0.00129	0.00455	CcSEcCtD
Cinoxacin—Abdominal pain—Azathioprine—systemic scleroderma	0.00128	0.00452	CcSEcCtD
Cinoxacin—Diarrhoea—Captopril—systemic scleroderma	0.00127	0.00449	CcSEcCtD
Cinoxacin—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.00127	0.00448	CcSEcCtD
Cinoxacin—Nausea—Mometasone—systemic scleroderma	0.00126	0.00443	CcSEcCtD
Cinoxacin—Anorexia—Lisinopril—systemic scleroderma	0.00125	0.00443	CcSEcCtD
Cinoxacin—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.00125	0.00442	CcSEcCtD
Cinoxacin—Pain—Mycophenolic acid—systemic scleroderma	0.00125	0.00441	CcSEcCtD
Cinoxacin—Dizziness—Captopril—systemic scleroderma	0.00123	0.00433	CcSEcCtD
Cinoxacin—Urticaria—Leflunomide—systemic scleroderma	0.00122	0.00429	CcSEcCtD
Cinoxacin—Abdominal pain—Leflunomide—systemic scleroderma	0.00121	0.00427	CcSEcCtD
Cinoxacin—Toxic epidermal necrolysis—Methotrexate—systemic scleroderma	0.0012	0.00422	CcSEcCtD
Cinoxacin—Hypersensitivity—Azathioprine—systemic scleroderma	0.00119	0.00422	CcSEcCtD
Cinoxacin—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.00119	0.00421	CcSEcCtD
Cinoxacin—Insomnia—Lisinopril—systemic scleroderma	0.00119	0.0042	CcSEcCtD
Cinoxacin—Paraesthesia—Lisinopril—systemic scleroderma	0.00118	0.00417	CcSEcCtD
Cinoxacin—Vomiting—Captopril—systemic scleroderma	0.00118	0.00417	CcSEcCtD
Cinoxacin—Rash—Captopril—systemic scleroderma	0.00117	0.00413	CcSEcCtD
Cinoxacin—Dermatitis—Captopril—systemic scleroderma	0.00117	0.00413	CcSEcCtD
Cinoxacin—Somnolence—Lisinopril—systemic scleroderma	0.00117	0.00413	CcSEcCtD
Cinoxacin—Headache—Captopril—systemic scleroderma	0.00116	0.00411	CcSEcCtD
Cinoxacin—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.00115	0.00407	CcSEcCtD
Cinoxacin—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.00115	0.00407	CcSEcCtD
Cinoxacin—Oedema—Mycophenolate mofetil—systemic scleroderma	0.00115	0.00407	CcSEcCtD
Cinoxacin—Decreased appetite—Lisinopril—systemic scleroderma	0.00114	0.00404	CcSEcCtD
Cinoxacin—Eosinophilia—Methotrexate—systemic scleroderma	0.00114	0.00401	CcSEcCtD
Cinoxacin—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.00113	0.00398	CcSEcCtD
Cinoxacin—Hypersensitivity—Leflunomide—systemic scleroderma	0.00113	0.00398	CcSEcCtD
Cinoxacin—Pain—Lisinopril—systemic scleroderma	0.00113	0.00397	CcSEcCtD
Cinoxacin—Diarrhoea—Azathioprine—systemic scleroderma	0.00111	0.00391	CcSEcCtD
Cinoxacin—Nausea—Captopril—systemic scleroderma	0.0011	0.00389	CcSEcCtD
Cinoxacin—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.0011	0.00388	CcSEcCtD
Cinoxacin—Pruritus—Leflunomide—systemic scleroderma	0.00108	0.00382	CcSEcCtD
Cinoxacin—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.00108	0.0038	CcSEcCtD
Cinoxacin—Dizziness—Azathioprine—systemic scleroderma	0.00107	0.00378	CcSEcCtD
Cinoxacin—Diarrhoea—Leflunomide—systemic scleroderma	0.00105	0.0037	CcSEcCtD
Cinoxacin—Urticaria—Lisinopril—systemic scleroderma	0.00105	0.00369	CcSEcCtD
Cinoxacin—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.00104	0.00368	CcSEcCtD
Cinoxacin—Abdominal pain—Lisinopril—systemic scleroderma	0.00104	0.00367	CcSEcCtD
Cinoxacin—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.00104	0.00365	CcSEcCtD
Cinoxacin—Pruritus—Mycophenolic acid—systemic scleroderma	0.00103	0.00365	CcSEcCtD
Cinoxacin—Vomiting—Azathioprine—systemic scleroderma	0.00103	0.00364	CcSEcCtD
Cinoxacin—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.00102	0.00362	CcSEcCtD
Cinoxacin—Drowsiness—Methotrexate—systemic scleroderma	0.00102	0.00361	CcSEcCtD
Cinoxacin—Rash—Azathioprine—systemic scleroderma	0.00102	0.00361	CcSEcCtD
Cinoxacin—Dermatitis—Azathioprine—systemic scleroderma	0.00102	0.0036	CcSEcCtD
Cinoxacin—Headache—Azathioprine—systemic scleroderma	0.00102	0.00358	CcSEcCtD
Cinoxacin—Stevens-Johnson syndrome—Methotrexate—systemic scleroderma	0.00102	0.00358	CcSEcCtD
Cinoxacin—Dizziness—Leflunomide—systemic scleroderma	0.00101	0.00357	CcSEcCtD
Cinoxacin—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.001	0.00354	CcSEcCtD
Cinoxacin—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.001	0.00353	CcSEcCtD
Cinoxacin—Pain—Mycophenolate mofetil—systemic scleroderma	0.000986	0.00348	CcSEcCtD
Cinoxacin—Vomiting—Leflunomide—systemic scleroderma	0.000974	0.00344	CcSEcCtD
Cinoxacin—Hypersensitivity—Lisinopril—systemic scleroderma	0.00097	0.00342	CcSEcCtD
Cinoxacin—Dizziness—Mycophenolic acid—systemic scleroderma	0.000966	0.00341	CcSEcCtD
Cinoxacin—Rash—Leflunomide—systemic scleroderma	0.000966	0.00341	CcSEcCtD
Cinoxacin—Dermatitis—Leflunomide—systemic scleroderma	0.000965	0.0034	CcSEcCtD
Cinoxacin—Nausea—Azathioprine—systemic scleroderma	0.000963	0.0034	CcSEcCtD
Cinoxacin—Headache—Leflunomide—systemic scleroderma	0.000959	0.00338	CcSEcCtD
Cinoxacin—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000943	0.00333	CcSEcCtD
Cinoxacin—Pruritus—Lisinopril—systemic scleroderma	0.000931	0.00328	CcSEcCtD
Cinoxacin—Vomiting—Mycophenolic acid—systemic scleroderma	0.000929	0.00328	CcSEcCtD
Cinoxacin—Rash—Mycophenolic acid—systemic scleroderma	0.000921	0.00325	CcSEcCtD
Cinoxacin—Dermatitis—Mycophenolic acid—systemic scleroderma	0.00092	0.00325	CcSEcCtD
Cinoxacin—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000916	0.00323	CcSEcCtD
Cinoxacin—Headache—Mycophenolic acid—systemic scleroderma	0.000915	0.00323	CcSEcCtD
Cinoxacin—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000911	0.00322	CcSEcCtD
Cinoxacin—Nausea—Leflunomide—systemic scleroderma	0.00091	0.00321	CcSEcCtD
Cinoxacin—Diarrhoea—Lisinopril—systemic scleroderma	0.0009	0.00318	CcSEcCtD
Cinoxacin—Angioedema—Prednisone—systemic scleroderma	0.000875	0.00309	CcSEcCtD
Cinoxacin—Dizziness—Lisinopril—systemic scleroderma	0.00087	0.00307	CcSEcCtD
Cinoxacin—Erythema multiforme—Methotrexate—systemic scleroderma	0.000869	0.00307	CcSEcCtD
Cinoxacin—Nausea—Mycophenolic acid—systemic scleroderma	0.000868	0.00306	CcSEcCtD
Cinoxacin—Tinnitus—Methotrexate—systemic scleroderma	0.000857	0.00302	CcSEcCtD
Cinoxacin—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000849	0.003	CcSEcCtD
Cinoxacin—Vomiting—Lisinopril—systemic scleroderma	0.000837	0.00295	CcSEcCtD
Cinoxacin—Rash—Lisinopril—systemic scleroderma	0.00083	0.00293	CcSEcCtD
Cinoxacin—Dermatitis—Lisinopril—systemic scleroderma	0.000829	0.00292	CcSEcCtD
Cinoxacin—Headache—Lisinopril—systemic scleroderma	0.000824	0.00291	CcSEcCtD
Cinoxacin—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000816	0.00288	CcSEcCtD
Cinoxacin—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000789	0.00278	CcSEcCtD
Cinoxacin—Nausea—Lisinopril—systemic scleroderma	0.000782	0.00276	CcSEcCtD
Cinoxacin—Oedema—Prednisone—systemic scleroderma	0.000782	0.00276	CcSEcCtD
Cinoxacin—Anaphylactic shock—Prednisone—systemic scleroderma	0.000782	0.00276	CcSEcCtD
Cinoxacin—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000762	0.00269	CcSEcCtD
Cinoxacin—Anorexia—Prednisone—systemic scleroderma	0.000745	0.00263	CcSEcCtD
Cinoxacin—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000733	0.00259	CcSEcCtD
Cinoxacin—Rash—Mycophenolate mofetil—systemic scleroderma	0.000727	0.00256	CcSEcCtD
Cinoxacin—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000726	0.00256	CcSEcCtD
Cinoxacin—Headache—Mycophenolate mofetil—systemic scleroderma	0.000722	0.00255	CcSEcCtD
Cinoxacin—Insomnia—Prednisone—systemic scleroderma	0.000707	0.00249	CcSEcCtD
Cinoxacin—Paraesthesia—Prednisone—systemic scleroderma	0.000702	0.00248	CcSEcCtD
Cinoxacin—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000685	0.00242	CcSEcCtD
Cinoxacin—Decreased appetite—Prednisone—systemic scleroderma	0.000679	0.0024	CcSEcCtD
Cinoxacin—Anaphylactic shock—Methotrexate—systemic scleroderma	0.000653	0.0023	CcSEcCtD
Cinoxacin—Thrombocytopenia—Methotrexate—systemic scleroderma	0.00064	0.00226	CcSEcCtD
Cinoxacin—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000639	0.00225	CcSEcCtD
Cinoxacin—Anorexia—Methotrexate—systemic scleroderma	0.000623	0.0022	CcSEcCtD
Cinoxacin—Urticaria—Prednisone—systemic scleroderma	0.000621	0.00219	CcSEcCtD
Cinoxacin—Abdominal pain—Prednisone—systemic scleroderma	0.000618	0.00218	CcSEcCtD
Cinoxacin—Insomnia—Methotrexate—systemic scleroderma	0.000591	0.00208	CcSEcCtD
Cinoxacin—Paraesthesia—Methotrexate—systemic scleroderma	0.000586	0.00207	CcSEcCtD
Cinoxacin—Somnolence—Methotrexate—systemic scleroderma	0.000581	0.00205	CcSEcCtD
Cinoxacin—Hypersensitivity—Prednisone—systemic scleroderma	0.000576	0.00203	CcSEcCtD
Cinoxacin—Decreased appetite—Methotrexate—systemic scleroderma	0.000568	0.002	CcSEcCtD
Cinoxacin—Pain—Methotrexate—systemic scleroderma	0.000559	0.00197	CcSEcCtD
Cinoxacin—Pruritus—Prednisone—systemic scleroderma	0.000553	0.00195	CcSEcCtD
Cinoxacin—Diarrhoea—Prednisone—systemic scleroderma	0.000535	0.00189	CcSEcCtD
Cinoxacin—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000534	0.00188	CcSEcCtD
Cinoxacin—Urticaria—Methotrexate—systemic scleroderma	0.000519	0.00183	CcSEcCtD
Cinoxacin—Dizziness—Prednisone—systemic scleroderma	0.000517	0.00182	CcSEcCtD
Cinoxacin—Abdominal pain—Methotrexate—systemic scleroderma	0.000516	0.00182	CcSEcCtD
Cinoxacin—Vomiting—Prednisone—systemic scleroderma	0.000497	0.00175	CcSEcCtD
Cinoxacin—Rash—Prednisone—systemic scleroderma	0.000493	0.00174	CcSEcCtD
Cinoxacin—Dermatitis—Prednisone—systemic scleroderma	0.000492	0.00174	CcSEcCtD
Cinoxacin—Headache—Prednisone—systemic scleroderma	0.00049	0.00173	CcSEcCtD
Cinoxacin—Hypersensitivity—Methotrexate—systemic scleroderma	0.000481	0.0017	CcSEcCtD
Cinoxacin—Nausea—Prednisone—systemic scleroderma	0.000464	0.00164	CcSEcCtD
Cinoxacin—Pruritus—Methotrexate—systemic scleroderma	0.000462	0.00163	CcSEcCtD
Cinoxacin—Diarrhoea—Methotrexate—systemic scleroderma	0.000447	0.00158	CcSEcCtD
Cinoxacin—Dizziness—Methotrexate—systemic scleroderma	0.000432	0.00152	CcSEcCtD
Cinoxacin—Vomiting—Methotrexate—systemic scleroderma	0.000415	0.00147	CcSEcCtD
Cinoxacin—Rash—Methotrexate—systemic scleroderma	0.000412	0.00145	CcSEcCtD
Cinoxacin—Dermatitis—Methotrexate—systemic scleroderma	0.000411	0.00145	CcSEcCtD
Cinoxacin—Headache—Methotrexate—systemic scleroderma	0.000409	0.00144	CcSEcCtD
Cinoxacin—Nausea—Methotrexate—systemic scleroderma	0.000388	0.00137	CcSEcCtD
